Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label, Fixed-dose Multiple Administration Study to Evaluate Long-term Treatment With Eptinezumab in Patients With Chronic Cluster Headache

NCT05064397 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT05064397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05064397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label, Fixed-dose Multiple Administration Study to Evaluate Long-term Treatment With Eptinezumab in Patients With Chronic Cluster Headache
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
September 17, 2021
Completion date
June 29, 2023
Enrollment
131 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

chronic cluster headache